[ Price : $8.95]
FDA deals Sarepta Therapeutics another blow by asking for additional data to be included in the companys planned NDA for eteplirse...[ Price : $8.95]
FDA approves a St. Jude Medical PMA for its TactiCath Quartz irrigated ablation catheter, a real-time objective measure of the for...[ Price : $8.95]
A new CBER draft guidance outlines certain exemptions for procedures involving human cells, tissues or cellular or tissue-based pr...[ Price : $8.95]
FDA approves a Baxter Healthcare BLA for Obizur [antihemophilic factor (recombinant), porcine sequence] for treating bleeding epis...[ Price : $8.95]
FDA grants MediciNova an orphan-drug designation for MN-001 (tipelukast) for treating idiopathic pulmonary fibrosis.[ Price : $8.95]
Rich Pharmaceuticals submits an IND application to FDA for a Phase 2 clinical trial of its RP-323 in patients with acute myelocyti...[ Price : $8.95]
A Dallas jury finds that Johnson & Johnsons DePuy unit did not market defective metal-on-metal hip implants.[ Price : $8.95]
FDA releases a draft guidance on Qualification of Biomarker Galactomannan in studies of treatments of Invasive Aspergillosis that...